Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2.
Yang J, Weisberg EL, Qi S, Ni W, Mei H, Wang Z, Meng C, Zhang S, Hou M, Qi Z, Wang A, Jiang Y, Jiang Z, Huang T, Liu Q, Magin RS, Doherty L, Wang W, Liu J, Buhrlage SJ, Liu Q, Griffin JD.
Yang J, et al. Among authors: ni w.
Leukemia. 2022 Apr;36(4):1048-1057. doi: 10.1038/s41375-021-01494-w. Epub 2022 Jan 17.
Leukemia. 2022.
PMID: 35034955